Skip to main content
Equibles

Logos Global Management LP

Position in IMVT — Immunovant, Inc.

CIK 1792126 San Francisco, CA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,622,450
-$1,080,550 QoQ
Shares Held
665,000
-38.1% QoQ
Ownership
0.322%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#30
of 226 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Logos Global Management LP holds $2,282,084,584 across 63 Biotechnology names. IMVT ranks #29 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ERAS
Erasca, Inc.
 12,150,000 $222,588,000
2 ABVX
Abivax S.A.
 1,024,000 $136,458,240
3 RVMD
Revolution Medicines, Inc.
 700,000 $131,096,000
4 IDYA
IDEAYA Biosciences, Inc.
 3,000,000 $111,810,000
5 BNTX
BioNTech SE
 1,015,000 $94,445,750
6 VERA
Vera Therapeutics, Inc.
 2,200,000 $94,402,000
7 TNGX
Tango Therapeutics, Inc.
 2,850,000 $89,091,000
8 PRAX
Praxis Precision Medicines, Inc.
 260,000 $87,045,400

All Filings in IMVT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,622,450 665,000
2026-03-31 $26,703,000 1,075,000
2025-12-31 $34,952,500 1,375,000
2025-09-30 $4,433,000 275,000
2025-06-30 $4,400,000 275,000
2025-03-31 $4,699,750 275,000
2024-12-31 $7,431,000 300,000
2024-09-30 $31,361,000 1,100,000
2024-06-30 $15,180,000 575,000
2024-03-31 $57,350,250 1,775,000
2023-12-31 $50,556,000 1,200,000
2023-09-30 $61,424,000 1,600,000
2023-06-30 $42,682,500 2,250,000
2023-03-31 $38,775,000 2,500,000
2022-12-31 $55,912,500 3,150,000
2020-06-30 $15,218,750 625,000